Raphael Mechoulam is an Israeli professor of Medicinal Chemistry and Natural Products Chemistry at the Hebrew University of Jerusalem. While working on research at the Weizmann Institute of Science in 1964 succeeded Michoulam in the isolation, structure elucidation and total synthesis of D9-tetrahydrocannabinol, the main active ingredient of cannabis.

This video discusses what THC does to the brain, also touches on the 1992 discovery of anandamide, also known as N-arachidonoylethanolamine or AEA, an endogenous cannabinoid neurotransmitter that is in human organs known. If the compound is released into the brain is concerned memory, appetite and pain. It was isolated and its structure was described in 1992.

In recent years, Professor Mechoulam, has been a great inspiration for activists, doctors, scientists and citizens around the world cure for his dedication and constant quest for you to be devastatingGoverning human disorders such as PTSD and chronic pain.

Source: Botany of Desire



For more information:cannabis neuroprotectiveMS Patients Visit MS Society, DC, Part 1

Newsflash: 31 July 2008 - The National (U.S.) Multiple Sclerosis Society has recognized the healing properties of cannabis in MS patients

September 2003 - After attending a memorial at the Supreme Court of MS guy! Patient Cheryl Miller, members of the Multiple Sclerosis Patients Union to the National MS Society converge headquarters to insist that the U.S. group to follow the lead of the British MS Society and support the use of medical cannabis (marijuana ) for MS sufferers.
Stay tuned for Part 2 - The patient talk to the MS Society
The National Organization for the Reform of Marijuana Laws

and the Marijuana Policy Project
< br /> supports. MS patients Union in this case
Multiple Sclerosis Patients Union.